申请人:SAGE THERAPEUTICS, INC.
公开号:US20160022701A1
公开(公告)日:2016-01-28
Provided are methods of evaluating or treating a patient, e.g., a patient having a disorder described herein, comprising: a) optionally, acquiring a patient sample; b) acquiring an evaluation of and/or evaluating the sample for an alteration in the level S24(S)-hydroxycholesterol compared to a reference standard.
提供了评估或治疗患者的方法,例如,患有本文所述疾病的患者,包括:a) 可选地,获取患者样本;b) 获取对样本的评估和/或评估其S24(S)-羟基胆固醇水平与参考标准相比是否发生改变。